The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma

Current Eye Research

Volumn 28, Issue 3, 2004, Pages 153-157

  Hirooka, Kazuyuki ^a   Tokuda, Masaaki ^a   Miyamoto, Osamu ^a   Itano, Toshifumi ^a   Baba, Tetsuya ^a   Shiraga, Fumio ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Ganglion cell; Glaucoma; Glaucoma pharmacology; Intraocular pressure; Nitric oxide

Indexed keywords

FAST BLUE; GINKGO BILOBA EXTRACT; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUTERIZATION; CELL COUNT; CELL DENSITY; CELL LABELING; CELL LOSS; CELL SURVIVAL; CHRONIC DISEASE; CONTROLLED STUDY; DEGENERATION; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE ABNORMALITY; MEASUREMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OCULAR BLOOD VESSEL; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; SUPERIOR COLLICULUS;

ANIMALS; CELL COUNT; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GINKGO BILOBA; GLAUCOMA; INTRAOCULAR PRESSURE; NEUROPROTECTIVE AGENTS; OCULAR HYPERTENSION; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS;

EID: 1642404365     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.3.153.26246     Document Type: Article

References (38)

1. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340: 1136-1139.
2. Koc RK, Akdemir H, Kurtsoy A, Pasaoglu H, Kavuncu I, Pasaoglu A, Karakucuk I. Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba, TRH and methylprednisolone. Res Exp Med. 1995;195:117-123.
3. Piertri S, Maurelli E, Drieu K, Culcasi M. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol. 1997;29:733-742.
4. Iliff LD, Auer LM. The effect of intravenous infusion of Tebonin (Ginkgo biloba) on pial arteries in cats. J Neurosurg Sci. 1983;27:227-231.
5. Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. Prostaglandins. 1987;34:337-349.
6. Drieu K. Preparation and definition of Ginkgo biloba extract. Presse Med. 1986;15:1455-1457.
7. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun. 1994;201: 748-755.
8. Marcocci L, Packer L, Droy-Lefaix MT, Packer L. Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 1994;234:462-475.
9. 2+-induced increase in oxidative metabolism of dissociated mammalian brain neurons: Effect of extract of Ginkgo biloba leaves. Jpn J Pharmacol. 1993;61:367-370.
10. 2+-loaded brain neurons. Brain Res. 1994;635:125-129.
11. Bazan NG, Rodriguez de Turco EB. Accumulation of lipid-derived second messenger during seizures and ischemia: Decreased seizure-induved phospholipase C activation in the hippocampus by EGB 761, in advances in Ginkgo biloba Extract Research. Effect of Ginkgo biloba Extract (EGb 761) on the Central Nervous System. Paris: Elsevier; 1993:159-169.
12. Rodriguez de Turco EB, Droy-Lefaix MT, Bazan NG. Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): Selective effect in hippocampus as compared with cerebral cortex. J Neurochem. 1993;61:1438-1444.
13. Mattson MP. Neuroprotective signal transduction: Relevance to stroke. Neurosci Biobehav Rev. 1997;21:193-206.
14. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int. 1996;29:97-110.
15. Dawson VL, Dawson TM. Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med. 1996;211:33-40.
16. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13:2651-2661.
17. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke. 1997;28:1283-1288.
18. Goldstein IM, Ostwald P, Roth S. Nitric oxide: A review of its role in retinal function and disease. Vision Res. 1996;36:2979-2994.
19. Neufeld AH, Sawada A, Becker B. Inhibition of nitric oxide synthase-2 by aminoguanidine provide neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944-9948.
20. Kaufman PL. Nitric-oxide synthase and neurodegeneration/neuroprotection. Proc Natl Acad Sci USA. 1999;96: 9455-9456.
21. Hirooka K, Kourennyi DE, Barnes S. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. J Neurophysiol. 2000;83:198-206.
22. Glovinsky Y, Quigley HA, Dunkelberger G. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
23. Quigley HA, Dunkelberger G, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95:357-363.
24. Bastianetto S, Zheng W, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000;74:2268-2277.
25. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995;61:379-382.
26. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. San Diego: Academic Press; 1986.
27. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;43:521-531.
28. Kashii S, Mandai M, Kikuchi M, Honda Y, Tamura Y, Kaneda K, Akaike A. Dual actions of nitric oxide in N-methyl-D-asparate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res. 1996;711:93-101.
29. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP. Synthesis of nitric oxide in CNS glial cells. Trends Neursci. 1993;16:323-328.
30. Neufeld AH. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. J Glaucoma. 1998;7:434-438.
31. Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res. 1996;63:501-509.
32. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497-503.
33. Shareef S, Sawada A, Neufeld AH. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest Ophthalmol Vis Sci. 1999;40:2884-2891.
34. Drieu K. Preparation and definition of Ginkgo biloba extract. Press Med. 1986;15:1455-1457.
35. DeFeudis FV. Ginkgo biloba extract (EGb 761): Pharmacological Activities and Clinical Applications. Paris: Elsevier; 1991.
36. Bastianetto S, Zheng W-H, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000;74:2268-2277.
37. Wu WR, Zhu XZ. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Science. 1999;65: 157-164.
38. Droy-Lefaix MT, Menerath JM, Szabo-Tosaki E, Guillaumin D, Doly M. Protective effect of EGb 761 on ischemia-reperfusion damage in the rat retina. Transplantation Proceedings. 1995;27:2861-2862.